None listed
Conditions
Interventions
None listed
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: We prospectively enrolled 68 patients with gastric cancer between December 2014 and November 2019. Patients who were planned to undergo surgery (reduced-port [three-port] totally laparoscopic distal gastrectomy [Duet TLDG] D2 LN dissection) at Samsung Medical Center with a histological diagnosis of adenocarcinoma of the stomach; a Eastern Cooperative Oncology Group performance status of 0 or 1; age of between 20 and 80 years; location of the primary tumor in the antrum, angle, or low body; and clinical stage T1-3NxM0, which was determined with preoperative abdominal-pelvic computed tomography, endoscopy, and chest X-ray, were eligible for inclusion in this study.
Exclusion criteria
Exclusion criteria: We excluded patients with metastasis, double primary cancer, those receiving palliative treatment, and those who underwent the resection of another organ during gastrectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compliance rate : defined as cases in which there was no more than one missing LN station during D2 LN dissection | — |
Secondary
| Measure | Time frame |
|---|---|
| the numbers of dissected and retrieved LNs in each station and other short-term surgical outcomes and postoperative course | — |
Countries
Korea, Republic of
Contacts
Public ContactSung Eun Oh
Samsung Medical Center
Outcome results
None listed